Search Results - "Iarrobino, R."

Assessment of rebound and relapse following ecallantide treatment for acute attacks of hereditary angioedema by Bernstein, J. A., Shea, E. P., Koester, J., Iarrobino, R., Pullman, W. E.

“…Background Hereditary angioedema (HAE) is a rare genetic disease characterized by unpredictable and recurring attacks of angioedema. This study assessed…”
Get full text

Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor-Induced Angioedema: A Multicenter Randomized Controlled Trial by Lewis, L, Graffeo, C, Crosley, P, Klausner, H.A, Clark, C.L, Frank, A, Miner, J, Iarrobino, R, Chyung, Y

Get full text

Rates of Rebound or Relapse Among Acute Attacks of Hereditary Angioedema Treated with Ecallantide in Open-Label, Repeat-Treatment Study by Li, H.H, Bernstein, J.A, Soteres, D.F, Riedl, M, Lumry, W.R, Craig, T.J, MacGinnitie, A.J, Iarrobino, R, Chyung, Y, Shea, E.P, Pullman, W.E

Get full text

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis by Banerji, Aleena, Busse, Paula, Shennak, Mustafa, Lumry, William, Davis-Lorton, Mark, Wedner, Henry J, Jacobs, Joshua, Baker, James, Bernstein, Jonathan A, Lockey, Richard, Li, H. Henry, Craig, Timothy, Cicardi, Marco, Riedl, Marc, Al-Ghazawi, Ahmad, Soo, Carolyn, Iarrobino, Ryan, Sexton, Daniel J, TenHoor, Christopher, Kenniston, Jon A, Faucette, Ryan, Still, J. Gordon, Kushner, Harvey, Mensah, Robert, Stevens, Chris, Biedenkapp, Joseph C, Chyung, Yung, Adelman, Burt

“…In patients with hereditary angioedema with C1 inhibitor deficiency, swelling episodes are related to the release of bradykinin from high-molecular-weight…”
Get full text

SMA – THERAPY: P.253 Clinical Development of SRK-015, a Fully Human Anti-proMyostatin Monoclonal Antibody, for the Treatment of Later-Onset Spinal Muscular Atrophy by Place, A., Barrett, D., Cote, S., Nomikos, G., Iarrobino, R., Yung, C.

Get full text

SMA – THERAPY by Place, A., Barrett, D., Cote, S., Nomikos, G., Iarrobino, R., Yung, C.

Get full text

SMA - TREATMENT by Place, A., Barrett, D., Cote, S., Nomikos, G., Song, G., Bilic, S., Kalra, A., Sadanowicz, M., O'Neil, J., Iarrobino, R., Kertesz, N., Chyung, Y.

Get full text

SMA - TREATMENT: EP.277 Insights into the potential pharmacological effects of apitegromab in health and disease: Data from preclinical and clinical studies by Place, A., Barrett, D., Cote, S., Nomikos, G., Song, G., Bilic, S., Kalra, A., Sadanowicz, M., O'Neil, J., Iarrobino, R., Kertesz, N., Chyung, Y.

Get full text

P.126SRK-015, a fully human monoclonal antibody inhibiting myostatin activation, offers sustained target engagement across multiple species, including humans by Kalra, A., Cote, S., Barrett, D., Long, K., Kavosi, M., Wawersik, S., Faulds, H., Treece, E., Iarrobino, R., Chyung, Y.

Get full text